| TSNAX-DISC1 |
|
TSNAX-DISC1 readthrough (NMD candidate)
|
|
|
0.729 |
0.154 |
6
|
| IFNA1 |
P01562
|
interferon alpha 1
|
|
|
0.371 |
0.923 |
4
|
| NEFL |
P07196
|
neurofilament light
|
|
|
0.488 |
0.769 |
4
|
| DAOA-AS1 |
|
DAOA antisense RNA 1
|
|
|
0.729 |
0.154 |
4
|
| ABO |
P16442
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
|
Enzyme
|
|
0.427 |
0.885 |
3
|
| ADH1C |
P00326
|
alcohol dehydrogenase 1C (class I), gamma polypeptide
|
Enzyme
|
|
0.547 |
0.731 |
3
|
| HLA-DRB4 |
P13762
|
major histocompatibility complex, class II, DR beta 4
|
Immune response
|
|
0.565 |
0.846 |
3
|
| CSMD2 |
Q7Z408
|
CUB and Sushi multiple domains 2
|
|
|
0.695 |
0.269 |
3
|
| DCANP1 |
Q8TF63
|
dendritic cell associated nuclear protein
|
|
|
0.839 |
0.154 |
3
|
| MIR206 |
|
microRNA 206
|
|
|
0.477 |
0.846 |
3
|
| MIR30E |
|
microRNA 30e
|
|
|
0.576 |
0.769 |
3
|
| GTS |
|
Gilles de la Tourette syndrome
|
|
|
0.682 |
0.615 |
2
|
| MS |
|
multiple sclerosis
|
|
|
0.599 |
0.692 |
2
|
| COX2 |
P00403
|
cytochrome c oxidase subunit II
|
Enzyme
|
|
0.352 |
0.962 |
2
|
| SRD5A2 |
P31213
|
steroid 5 alpha-reductase 2
|
Enzyme
|
|
0.564 |
0.615 |
2
|
| ERDA1 |
|
expanded repeat domain, CAG/CTG 1
|
|
|
0.736 |
0.154 |
2
|
| DISC2 |
|
disrupted in schizophrenia 2
|
|
|
0.716 |
0.192 |
2
|
| ERVW-1 |
Q9UQF0
|
endogenous retrovirus group W member 1, envelope
|
|
|
0.505 |
0.692 |
2
|
| MIR382 |
|
microRNA 382
|
|
|
0.603 |
0.692 |
2
|
| MIR1202 |
|
microRNA 1202
|
|
|
0.729 |
0.385 |
2
|
| DLG2-AS1 |
|
DLG2 antisense RNA 1
|
|
|
0.861 |
0.077 |
2
|
| MIR2682 |
|
microRNA 2682
|
|
|
0.805 |
0.154 |
2
|
| ERVW-4 |
|
endogenous retrovirus group W member 4
|
|
|
0.686 |
0.615 |
2
|
| FRA7G |
|
fragile site, aphidicolin type, common, fra(7)(q31.2)
|
|
|
0.695 |
0.462 |
1
|